Document is current
Any future updates will be listed below
-
Authors
von Ostau, Nicola E.
Martynov, Aleksandr
Schreiber, Janina
Wiesehöfer, Marc
Hadaschik, Boris A.
Temme, Christian
Stang, Andreas
Dankert, Jaroslaw T.
Wiesehöfer, Caroline
Wennemuth, Gunther https://orcid.org/0000-0003-3313-2475
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 4 May 2023
Revised: 12 November 2023
Accepted: 4 December 2023
First Online: 4 January 2024
Declarations
:
: B.A.H. has had advisory roles for ABX, AAA/Novartis, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Janssen R&D, Lightpoint Medical, Inc., and Pfizer; has received research funding from Astellas, Bristol Myers Squibb, AAA/Novartis, German Research Foundation, Janssen R&D, and Pfizer; and has received compensation for travel from Astellas, AstraZeneca, Bayer and Janssen R&D, all outside the submitted work. N.E.O. has received compensation for travel from Janssen R&D, outside the submitted work. All other authors have stated explicitly that there are no conflicts of interest in connection with this article.
: All experiments with human spermatozoa have been approved by the Ethics Committee of the University of Duisburg-Essen (14-5748-BO and Addendum 11/2019).
